This second series of on-line continuing education presentations will inform participants of what we know about withdrawing from psychiatric medications. This set of 8 monthly webinars will focus on the views of internationally recognized psychiatrists and begin on June 19 with a town hall session hosted by Robert Whitaker with 3 participants. One will be a person with lived experience in withdrawing, the second and third will be a psychiatrist and a psychologist.
Times for the webinars will be 1:30-3 PM Eastern US; 10:30 AM-Noon Pacific. Because several of our presenters are internationally-based, there may be some slight time changes but we will announce them as soon as possible. All webinars will be posted immediately after the "live" events so that they will be available for viewing by all registered students for at least one year afterward.
The schedule for the webinars is as follows:
June 18, 2018: Robert Whitaker Town Hall
Town Hall discussion on key issues from 3 perspectives: a psychiatrist, a psychologist and a person with lived experience in withdrawing.
July 17, 2018: Joanna Moncrieff, MD
The nature of psychiatric drugs, what we know and don't know about what they do to the brain with repeated and long-term use and how these changes affect the experience of withdrawal; study on antidepressant withdrawal and antipsychotic withdrawal.
August 21, 2018: Sandy Steingard, MD
Working in a public health clinic: what are the barriers to providing clients with withdrawal information and support for those who want to taper from the medications? What has she learned since she implemented a withdrawal program six years ago?
September 18, 2018: David Healy, MD and Johanna Ryan
SSRIs and sexual dysfunction: A look at this adverse effect during SSRI use, and PSSD: sexual dysfunction that persists after withdrawal, and what this may signal regarding renormalization of serotonergic function.
October 16, 2018: Sami Timimi, MD
Withdrawal issues with children and adolescents, challenges and opportunities
November 20, 2018: Swapnil Gupta, MD
Applying the basic principles of deprescribing to psychiatry: An intervention aimed at reducing the use of inappropriate medications, deprescribing was initially introduced by the field of geriatric medicine. In this talk, Dr. Gupta will discuss how deprescribing can serve as a model to reduce the superfluous use of psychotropic medications and how it can be modified for use in psychiatric settings.
December 11, 2018: Pesach Lichtenberg, MD
Psychiatric drug withdrawal in Israel's Soteria House programs
January 15, 2018: Roger Mulder, MD
Antidepressant withdrawal study: Results, and protocols used, and lessons learned from it.
These topics are among the least understood and most critical issues facing psychiatry in the decades ahead given the fact that well-constructed unbiased research shows clearly that most individuals do better in the mid- to long-term if they can reduce their reliance on psychiatric medications.
Note: This series is not designed to provide advice to individuals who are seeking to taper from their medications. It is, instead, designed to explore the risks and rewards of doing so, and methods for doing so successfully. It is also designed to identify the many shortcomings in our medical and societal knowledge about withdrawing from psychiatric drugs.
Who should view this series
All previous webinars in the project have been approved for CEs for psychologists, nurses, licensed marriage and family therapists, and professional counselors. Applications will be submitted for each of these sessions and we anticipate approval. If we receive a significant number of MDs who enroll, we will apply for CMEs.
The fee for individuals is $100 for the eight webinar course. However, there is an EARLY BIRD discount of $50 for those who register by May 1. Use coupon code: EARLY-BIRD.
We are offering a limited number of full and partial scholarships for peers and non-professionals. Click here to apply for a scholarship.
Organizational Fee: Organizations may purchase registrations for up to 25 students at a discounted price. Please contact Bob Nikkel at email@example.com or (503) 929-9346 for more information.
June 18, 2018
Robert Whitaker is an American journalist and author who has won numerous awards as a journalist covering medicine and science, including the George Polk Award for Medical Writing and a National Association for Science Writers’ Award for best magazine article. In 1998, he co-wrote a series on psychiatric research for the Boston Globe that was a finalist for the Pulitzer Prize for Public Service. His first book, Mad in America, was named by Discover magazine as one of the best science books of 2002. Anatomy of an Epidemic won the 2010 Investigative Reporters and Editors book award for best investigative journalism. He is the publisher of madinamerica.com.
July 17, 2018
Joanna Moncrieff, M.D. is a psychiatrist, academic and author. She has an interest in the history, philosophy and politics of psychiatry, and particularly in the use, misuse and misrepresentation of psychiatric drugs. As an author, Dr. Moncrieff has written extensively on psychiatric drugs and her books include The Myth of the Chemical Cure, A Straight Talking Introduction to Psychiatric Drugs and The Bitterest Pills: the troubling story of antipsychotic drugs. She is one of the founding members of the Critical Psychiatry Network which consists of psychiatrists from around the world who are skeptical of the idea that mental disorders are simply brain diseases and of the dominance of the pharmaceutical industry.
August 21, 2018
Sandra Steingard, M.D. is Associate Clinical Professor of Psychiatry at University of Vermont Larner College of Medicine and Chief Medical Officer at Howard Center, a community mental health center in Burlington, Vermont where she has worked for the past 22 years. For over 25 years her clinical practice has primarily included patients with schizophrenia and other psychotic illnesses. She was named to Best Doctors in America in 2003. She currently writes a blog called “Anatomy of a Psychiatrist” a www.madinamerica.com. She has served on the board of the Foundation for Excellence in Mental Health Care since 2012 and has served as chair since 2016.
In recent years, her main areas of interest have been in using antipsychotic drugs in a more selective ways and integrating Open Dialogue practices into her clinic. Along with colleagues, she has developed a Vermont-based need-adapted program called Collaborative Network Approach. Dr. Steingard has presented a previous course for Mad In America Continuing Education, “Antipsychotics: Short and Long-term Effects.” She has lectured around the world on these topics. She chaired a workshop and symposium at American Psychiatric Association meetings on the optimal use of antipsychotic drugs. She has tracked a series of individuals who have been tapering their doses of antipsychotic drugs and will present this data in this lecture.
September 18, 2018
David Healy, M.D. is an internationally respected psychiatrist, psychopharmacologist, scientist, and author. A professor of psychiatry in Wales, David studied medicine in Dublin, and at Cambridge University. He is a former Secretary of the British Association for Psychopharmacology and has authored more than 200 peer-reviewed articles and 20 books, including The Antidepressant Era, The Creation of Psychopharmacologyand his latest book, Pharmageddon, published in 2012. David is a founder and CEO of Data Based Medicine Limited, which operates through its website RxISK.org, and is dedicated to making medicines safer through online direct patient reporting of drug side effects.
Johanna Ryan is a workers’ comp paralegal and a union and healthcare activist in Chicago. She may or may not have a biological brain disease, but she is definitely allergic to capitalism and addicted to asking questions.
October 16, 2018
Sami Timimi, M.D. is a Consultant Child and Adolescent Psychiatrist and a Visiting Professor of Child and Adolescent Psychiatry based in Lincoln, UK. He writes from a critical psychiatry perspective and has published many articles and books including Naughty Boys: Anti-Social Behaviour, ADHD, and the Role of Culture (2005), A Straight Talking Introduction to Children’s Mental Health Problems (2009) and most recently The Myth of Autism: Medicalising Men’s and Boys’ Social and Emotional Competence (2010). He is founder member of the International Critical Psychiatry Network and recently launched the No More Psychiatric Labels campaign to abolish formal psychiatric diagnostic systems.
November 20, 2018
Swapnil Gupta, M.D., M.B.B.S. is a psychiatrist who received most of her foundational training in medicine and psychiatry in Pondicherry and Chandigarh in India. She completed a second residency and a psychopharmacology fellowship at SUNY Downstate and Yale. Her interest in deprescribing emerges from a critical clinical need for such an intervention in psychiatry, her experience of having worked in settings with limited access to medications and her strong inclination toward rational and parsimonious use of medications. She works as Assistant Professor of Psychiatry at the Yale School of Medicine where she teaches clinical interviewing and psychopharmacology to medical students and psychiatry residents. She also works as outpatient attending psychiatrist at the Connecticut Mental Health Center.
December 11, 2018
Pesach Lichtenberg, M.D., is a Jerusalem psychiatrist and former Head of Psychiatry at the medical school of the Hebrew University in Jerusalem, where he continues to serve as Clinical Associate Professor. He left his position as head of a closed psychiatric ward in order to establish Soteria Israel, which currently operates two Soteria homes in Jerusalem.
January 15, 2019
Roger Mulder, MBChB, PhD is a Professor of Psychological Medicine at the University of Otago. His academic interests include mood disorders, personality disorders, genetics, neurobiology, suicide, and early psychosis. He is interested in the history and philosophy of psychiatry, particularly the classification of abnormal behaviour. Dr. Mulder is also involved in research on the psychiatric aspects of medical illnesses. He has published over 150 articles and book hapters. He is editor of the journal Personality and Mental Health, associate editor of the New Zealand Medical Journal and serves on several editorial boards.